Keywords: aDMN; anterior default mode network; BOLD; blood oxygen level-dependent; CI; cognitive impairment; CNI; cognitive nonimpairment; CC; corpus callosum; DMN; default mode network; DLPFC; dorsolateral prefrontal cortex; DPABI; Data Processing & Analysis for (
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: immunosuppression; incidence; liver transplantation; phenotype; predictive factors; skin cancer; BCC; basal cell carcinoma; CNI; calcineurin inhibitor; KTR; kidney transplant recipient; LTR; liver transplant recipient; mTORi; mammalian target of rapamycin
Keywords: CNI; calcineurin inhibitor(s); DC; dendritic cell(s); DCreg; regulatory DC(s); IS; immunosuppressive(ion); SOC; standard of care; Treg; regulatory T cell(s; Dendritic cells; Cell therapy; Liver transplantation; Tolerance;
Keywords: BATF; basic leucine zipper transcription factor; BM; bone marrow; Bregs; regulatory B cells; BTLA; B and T lymphocyte attenuator; CFSE; carboxyfluorescein succinimidyl ester; CML; cell mediated lympholysis; CNI; calcineurin inhibitor; CPM; counts per minu
Keywords: Donor-specific antibodies; Chronic active antibody-mediated rejection; Kidney transplantation; Transplant glomerulopathy; Treatment; ABMR; antibody-mediated rejection; Anti-IL2R-ab; anti-interleukin-2 receptor antibody; ATG; anti-thymocyte globulin; CAABM
Keywords: Steroid receptor genes; Steroid conversion; Transplantation; Kidney; Tolerance; Chronic rejection; 11β-HSD; 11β-Hydroxysteroid dehydrogenase; C1s; Complement component 1, s subcomponent gene; CISH; Cytokine inducible SH2-containing protein gene; CNI; ca
Keywords: ALK PHOS; alkaline phosphatase; ALT; alanine aminotransferase (serum glutamate-pyruvate transaminase (SGPT)); AST; aspartate aminotransferase (serum glutamic oxaloacetic transaminase (SGOT)); BUN; blood urea nitrogen; CA; calcium; CI; confidence interval;
Keywords: BPAR; biopsy proven acute cellular rejection; CD; cluster of differentiation; CI; confidence interval; CNI; calcineurin inhibitor; DNA; deoxyribonucleic acid; DSA; donor-specific human leukocyte antigen alloantibody; HPA; human platelet antigen; GP; glyco
Keywords: cardiac allograft vasculopathy; heart transplantation; immunosuppression; stem cells; tissue engineering; transplant rejection; ACR; acute cellular rejection; AMR; antibody-mediated rejection; CMR; cardiac magnetic resonance; CNI; calcineurin inhibitor; C
Keywords: cfDNA; cell-free DNA; CNI; copy number instability; ctDNA; circulating tumor cell-free DNA; ddPCR; droplet digital PCR; GcfDNA; graft-derived cell-free DNA; LC-MS/MS; liquid chromatography tandem mass spectrometry; MIC; minimum inhibitory concentration; N
Keywords: SZ; Schizophrenia; BD; Bipolar disorder; HC; Healthy controls; NSS; Neurological Soft Signs; CSS; Cerebellar Soft Signs; NES; Neurological Evaluation Scale; ICARS; International Cooperative Ataxia Rating Scale; CNI; Cambridge Neurological Inventory; fMRI;
Keywords: Magnesium; Lymphocyte; Transplantation; Hospital admission; CMV; cytomegalovirus; CNI; calcineurin inhibitor; DCD; donation after circulatory death; EBV; Epstein Barr virus; HLA; human leukocyte antigen; NK; natural killer; PCR; polymerase chain reaction;
Keywords: ANZDATA; Australia and New Zealand Dialysis and Transplant Registry; BPAR; biopsy-proven acute rejection; CI; confidence interval; CNI; calcineurin inhibitor; CsA; cyclosporine; DSA; donor-specific antibody; HR; hazard ratio; IL-2R; interleukin 2 receptor
Keywords: AA; African American; Alb; albumin; ACE; Angiotensin converting enzyme; ACEI; Angiotensin converting enzyme inhibitor; ARB; Angiotensin II receptor blocker; CNI; Calcineurin inhibitor; CAU; Caucasian; CAN; Chronic allograft nephropathy; CKD; Chronic kidne
Keywords: AST; aspartate aminotransferase; BMI; body mass index; CI; confidence interval; CMV; cytomegalovirus; CNI; calcineurin inhibitor; CVA; cerebrovascular accident; DCD; donation after cardiac death; DM; diabetes mellitus; HLA; human leukocyte antigen; HTN; h
Keywords: Single-walled carbon nanotubes; Carbon nanotubes; Nanomaterials; Nanotoxicology; Pulmonary toxicology; Inflammation; Oxidative stress; Inhalation; Pharyngeal aspiration; Intratracheal instillation; ACE; angiotensin-converting enzyme; AD-SWCNTs; acetone/so
Keywords: ADHD; NSS; CNI; BRIEF
Keywords: AKI; acute kidney injury; CKD; chronic kidney disease; CNI; calcineurin-inhibitor; FEV1; forced expiratory volume in 1 second; FVC; forced vital capacity; HLTx; heart-lung transplantation; KTx; kidney transplantation; LTx; lung transplantation; 12; 34;
Keywords: MPA; mycophenolic acid; AUC; area under the curve; C0; trough level; MMF; mycophenolate mofetil; PK; pharmacokinetic; CNI; calcineurine inhibitor; TDM; therapeutic drug monitoring; POPPK; population pharmacokinetic; LSS; limited-sampling strategy; ITS; it
Keywords: AHR; adjusted hazard ratio; ALG; antilymphocyte globulin; ANZDATA; Australia and New Zealand Dialysis and Transplant Registry; aRR; adjusted relative risk; ATG; antithymocyte globulin; ATGAM; equine thymocyte globulin; ATS; antithymocyte serum; CI; confid
Keywords: ACEi; angiotensin-converting enzyme inhibitor; ADR; adverse drug reaction; CCB; calcium channel blocker; CKD; chronic kidney disease; CNI; calcineurin inhibitor; eGFR; estimated glomerular filtration rate; GFR; glomerular filtration rate; NSAID; nonsteroi
Keywords: TACT; acrolimus; PK; pharmacokinetics; AUC; area under the concentration time curve; C0; trough level; CYP3A; cytochrome P450 isoform 3A; Cmax; maximal concentration; CNI; calcineurin inhibitors; SS; steady state; CL; clearance; Tacrolimus; Poor execution
Keywords: calcineurin inhibitors; immunosuppression; mammalian target of rapamycin inhibitors; oncogenic viruses; organ transplant recipients; skin cancer; BCC; basal cell carcinoma; CI; confidence interval; CNI; calcineurin inhibitor; HPV; human papillomavirus; mT
Keywords: NFAT; nuclear factor of activated T cells; CFSE; carboxylfluorescein diacetate succinimidyl ester; CSA; cyclosporine; PRD; prednisolone; MPA; mycophenolic acid; MMF; mycophenolate mofetil; CNI; calcineurin inhibitor; CMV; cytomegalovirus; VZV; varicella z
Keywords: AIDS; acquired immunodeficiency syndrome; BCC; basal cell carcinoma; CNI; calcineurin inhibitor; EGFR; epidermal growth factor receptor; EMT; epithelial-mesenchymal transition; EV; epidermodysplasia verruciformis; HIV; human immunodeficiency virus; HPV;
Keywords: LT; liver transplantation; WD; Wilson's disease; FHF; fulminant hepatic failure; SFHF; subfulminant hepatic failure; CLD; chronic liver disease; CNI; calcineurin-inhibitor; MMF; mycophenolate mofetil; HCC; hepatocellular carcinoma; HAT; hepatic artery t
Keywords: LT; liver transplantation; HCC; hepatocellular carcinoma; CNI; calcineurin inhibitors; TC; trough concentrations; Liver transplantation; Hepatocellular carcinoma; Recurrence; Calcineurin inhibitors; Trough concentrations; Immunosuppression;
Keywords: NSS; Neurological Soft Signs; CNI; Cambridge Neurological Inventory; NES; Neurological Evaluation Scale; DSM-IV; Diagnostic and Statistical Manual of Mental Disorders, 4th. Edition; CPZ; Chlorpromazine Equivalent; PANSS; Positive and Negative Symptom Scal
Keywords: LT; liver transplantation; MC; Milan Criteria; HCC; hepatocellular carcinoma; CNI; calcineurine inhibitor; mTOR; mammalian target of rapamycin; UP; untreatable presentation/progression; BSC; best supportive care; AE; adverse event; CTCAE; common terminolo
Keywords: LT; liver transplantation; CNI; calcineurin inhibitors; LD; low-dose; SD; standard-dose; HCV; hepatitis C virus; LFT; liver function test; MMF; mycophenolate mofetil; mTOR; mammalian target of rapamycin; HBV; hepatitis B virus; Biopsy; Graft rejection; Im
Keywords: IS; immunosuppression; CNI; calcineurin inhibitor; HCV; hepatitis C virus; RCT; randomized clinical trial; ATG; anti-thymocyte globulin; MMF; mofetil mycophenolate; mTOR; mammalian target of rapamycin; RISET; reprogramming the immune system for the establ
Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity
Keywords: mTOR inhibitor; Liver; Transplantation; Regulatory T-cells; Calcineurin inhibitor.; CD; Cluster of differentiation; CNI; Calcineurin Inhibitor; EVR; Everolimus; HCC; Hepatocellular carcinoma; MMF; Mycophenolate Mofetil; PBMC; Peripheral Blood Mononuclear
De Novo Allergy and Immune-Mediated Disorders Following Solid-Organ Transplantation-Prevalence, Natural History, and Risk Factors
Keywords: transplantation; solid organ; liver; heart; kidney; intestine; multivisceral; allergy; autoimmunity; children; immune disorder; CNI; Calcineurin inhibitor; EBV; Epstein-Barr virus; EGID; Eosinophilic gastrointestinal disorder; HLH; Hemophagocytic lympho
Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients
Keywords: BMI; body mass index; CNI; calcineurin inhibitor; HR; hazard ratio; mTOR; mammalian target of rapamycin; SRTR; Scientific Registry of Transplant Recipients; SOT; solid organ transplant;
Great Hospitals of the Russian Federation: National Medical Research Center for Neurosurgery Named After N. N. Burdenko: History and Contemporaneity
Keywords: N. N. Burdenko Neurosurgery Institute; N. N. Burdenko Neurosurgery Center; Neurosurgery history; Russian neurosurgery; Education; CNI; Central Neurosurgical Institute; USSR; Union of Soviet Socialist Republics;
T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients
Keywords: ATG; anti-thymocyte globulin; AUC; area under curve; CI; confidence interval; CMI; cell-mediated immunity; CMV; cytomegalovirus; CNI; calcineurin inhibitor; D; donor; GCV; Ganciclovir; HLA; human leukocyte antigens; KTx; kidney transplant; M; Month; MMF;
YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy
Keywords: Calcineurin inhibitor; Renal fibrosis; YB-1; CNI-induced nephropathy; Subcellular shuttling; YB-1; Y-box protein-1; CNI; calcineurin inhibitor; MC; mesangial cell;
Mesenchymal stromal cells for tolerance induction in organ transplantation
Keywords: BM; bone marrow; CNI; calcineurin inhibitors; CsA; cyclosporine A; MMF; mycophenolate mofetil; MSC; mesenchymal stromal cells; Tregs; regulatory CD4+ T cells; RATG; rabbit anti-thymocyte globulin; Mesenchymal stromal cells; Kidney transplantation; Toleran
Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients
Keywords: ADAM; a disintegrin and metallopeptidase; CNI; calcineurin inhibitor; DGF; delayed graft function; DSA; donor-specific antibodyies; eGFR; estimated glomerular filtration rate; EVR; everolimus; CI; confidence interval; IF/TA; interstitial fibrosis/tubular
Activation of renal profibrotic TGFβ controlled signaling cascades by calcineurin and mTOR inhibitors
Keywords: AP-1; activator protein 1; CNI; calcineurin inhibitor(s); ECM; extracellular matrix; EMT; epithelial to mesenchymal transition; ERK; extracellular signal regulated kinase; FKBP; FK506 binding protein; JNK; Jun N-terminal kinase; LAP; latency-associated pr
Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus
Keywords: CMV; cytomegalovirus; CNI; calcineurin inhibitor; GVHD; graft-vs-host disease; HSCT; hematopoietic stem cell transplant; IV; intravenous; NO; nitric oxide; NOS; nitric oxide synthase;
ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model
Keywords: AUC(0-24); the area under the plasma concentration-time curves from 0 to 24Â h; Cmax; the maximum plasma concentration; CNI; calcineurin inhibitor; MS; multiple sclerosis; MST; median survival time; NHPs; nonhuman primates; PD; pharmacodynamic; PK; phar
Autophagy in allografts rejection: A new direction?
Keywords: Autophagy; Transplantation; Allograft; T lymphocyte; Tolerance; TCR; T cell receptor; I/R; Ischemia-reperfusion; PI3K; Phosphatidylinosito 3-kinase; mTOR; Mammalian target of rapamycin; CNI; Calcineurin inhibitor;
Epidermal Desmoglein 1 Expression Is Reduced in Kidney Transplant Recipients Compared with Immunocompetent Patients
Keywords: CNI; calcineurin inhibitor; Dsg; desmoglein; ICP; immunocompetent patient; KTR; kidney transplant recipient; SSC; squamous cell carcinoma;
Wound complications and surgical events in de novo heart transplant patients treated with everolimus: Post-hoc analysis of the SCHEDULE trial
Keywords: AE; adverse event; AZA; azathioprine; BMI; body mass index; CAV; cardiac allograft vasculopathy; CNI; calcineurin inhibitor; CyA; cyclosporine A; DM; diabetes mellitus; EVE; everolimus; HTx; heart transplant; ISHLT; International Society of Heart and Lung
14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation
Keywords: APC; antigen presenting cell; bp; base pair; C; cytosine; CD; cluster of differentiation; CI; confidence interval; CNI; calcineurin inhibitor; del; deletion; G; guanine; HBV; Hepatitis B Virus; HCC; Hepatocellular Carcinoma; HCV; Hepatitis C Virus; HLA-G;
Free microRNA levels in plasma distinguish T-cell mediated rejection from stable graft function after kidney transplantation
Keywords: ABMR; antibody-mediated rejection; AUC; area under the ROC curve; BL; borderline; CNI; calcineurin-inhibitor; CV; cross-validation; DSA; donor-specific antibodies; IFTA; interstitial fibrosis/tubular atrophy; MPA; mycophenolic acid; ROC; receiver operatin
'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review
Keywords: Liver allograft dysfunction; Autoimmunity; Molecular mimicry; Immunosuppression; Outcomes; dn-AIH; de novo autoimmune hepatitis; LT; liver transplantation; CNI; calcineurin inhibitor; GSTT1; glutathione s-transferase T1;
Research ArticleCounter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction
Keywords: CFSE; carboxyfluorescein succinimidyl ester; CNI; calcineurin inhibitor; CTLA-4; cytotoxic T lymphocyte antigen 4; DC; dendritic cell; HWE; Hardy Weinberg Equilibrium; LT; liver transplantation; PBMC; peripheral blood mononuclear cells; PD-1; programmed d
Research paperRapamycin safeguards lymphocytes from DNA damage accumulation in vivo
Keywords: CNI; calcineurin inhibitors; CSA; cyclosporine A; IL-2; interleukin-2; mTOR; mammalian Target Of Rapamycin; NFAT; nuclear factor of activated T cells; PBL; peripheral blood lymphocytes; PHA; phytohemagglutinin; RIN; RNA integrity; ROS; reactive oxygen spe